Latest filing published 07 Feb 2025 for Avid Bioservices, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard B. Hancock (board member) discloses dealings in Avid Bioservices, Inc. to SEC (Form 4). In total, 40 filings cover trades dated from 7 May 2021 to 5 February 2025.
The open-market side counts 1 purchase for €187k alongside 10 sales for €593k. Netting one side against the other leaves €406k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 27 option exercises.
Most recently, on 7 February 2025, the filings show a transaction in Avid Bioservices, Inc. The last insider purchase was made public on 10 January 2024, 1,012 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 40 declarations